Latest News & Features
Americas
DLA Piper has added two partners from Hogan Lovells to its IP and technology practice in New York. 25 September 2018
Big Pharma
The World Intellectual Property Organization and the International Federation of Pharmaceutical Manufacturers & Associations today launched an online tool designed to provide information on medical patents. 25 September 2018
Big Pharma
The EU General Court today rejected a trademark appeal brought by Swiss pharmaceutical company Novartis. 25 September 2018
Americas
The UK government has today confirmed that a “winter fact-finding mission” will soon be carried out by UK life sciences experts in Texas, building on the science and technology cooperation agreement signed by the UK and the US last year. 24 September 2018
Americas
US-based Allergan and the Saint Regis Mohawk Tribe have accused pharmaceutical company Amneal of infringing two patents in its generic version of an eye treatment. 24 September 2018
Americas
American biotech 3Scan is combining robotics with machine learning and automation to offer microscopy services for the 3D analysis of cells, tissues, and organs. LSIPR met general counsel Nada Rastad to hear about some of the patenting challenges. 24 September 2018
Asia-Pacific
The Australian Competition & Consumer Commission announced yesterday that it has approved the merger of generic drugs companies Arrow and Apotex. 21 September 2018
Europe
The English High Court has ruled that Gilead’s drug Truvada is not entitled to a supplementary protection certificate because it failed to meet the standards set out by Europe’s highest court earlier this year. 20 September 2018
Americas
ERS Genomics and the Broad Institute of MIT and Harvard signed CRISPR licensing deals with Thermo Fisher Scientific on Tuesday, shortly before ERS expanded a separate agreement with Oxford Genetics. 20 September 2018
Americas
Several recent cases from the US Court of Appeals for the Federal Circuit offer guidance on navigating the §101 legal framework with respect to CRISPR patent claims, as Pat Carson and Mira Atanassova Mulvaney of Kirkland & Ellis report. 19 September 2018